Hainan Introduces New Pricing Rules for Digital Therapeutics Effective June 1
The Hainan provincial healthcare security administration and health commission bureaus jointly issued the “Notice on...
Policy / Regulatory
UCB’s Keppra Procurement Resumed in Shanghai After Regulatory Halt
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has issued a notification resuming the procurement of UCB’s...
HHS Implements Trump’s Order for Most-Favored-Nation Drug Pricing
The U.S. Department of Health and Human Services (HHS) announced that it is taking immediate...
China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation
China’s Center for Drug Evaluation (CDE) has selected the 94th batch of reference preparations for...
China’s County Hospitals Show Improved Medical Service Capability in 2024
The National Health Commission (NHC) released a notice reporting the status of the county hospital...
NMPA Releases Updated List of Medical Devices Exempted from Clinical Evaluation
The National Medical Products Administration (NMPA) has released the latest version of the “List of...
NMPA Releases 92nd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 92nd batch of reference drugs for...
Trump Executive Order Seeks to Align US Prescription Drug Prices with Global Standards
U.S. President Donald J. Trump has signed an executive order aimed at aligning prescription drug...
Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality
The General Office of the People’s Government of Hainan Province has released the “Implementation Plan...
China’s CDE Reveals 93rd Batch of Reference Preparations for GQCE
China’s Center for Drug Evaluation (CDE) has released the 93rd batch of reference preparations for...
NHC Issues Guidelines for Geriatric Medicine Departments Construction and Management
The National Health Commission (NHC) this week released the “Guidelines for the Construction and Management...
China’s NMPA Releases Draft Guidelines for Development Risk Management Plan
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) released the...
China’s 13 Ministries Release Guidance to Optimize Primary Healthcare Institutions
The National Health Commission, National Development and Reform Commission, and State Commission Office of Public...
NMPA Issues New Quality Management Standards for Online Medical Device Sales
The National Medical Products Administration (NMPA) has released the “Announcement on Quality Management Standards for...
NHSA Launches Intelligent Supervision Reform Pilot in Designated Medical Institutions
The National Healthcare Security Administration (NHSA) has released a notification to implement an intelligent supervision...
Digital-Intelligent Transformation of China’s Pharmaceutical Industry: 2025-2030 Plan Unveiled
China’s Ministry of Industry and Information Technology, Ministry of Commerce, National Health Commission (NHC), and...
Trump Administration Considers Tying US Drug Prices to International Benchmarks
Reuters reported that the Trump administration is exploring a policy to tie domestic drug prices...
NMPA Issues 91st Batch of Reference Standards for Generic Drug Quality Evaluation
The National Medical Products Administration (NMPA) has released the 91st batch of reference standards for...
China’s Medical Insurance Payment Reform Achieves Nationwide Coverage, Faces Challenges Ahead
The first blue book on the reform of China’s medical insurance payment methods, titled “Report...
Shanghai Healthcare Administration Pushes for 11th Round of VBP
Shanghai’s Healthcare Security Administration (HSA) bureau held a work conference on April 16, 2025, to...